Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| IDRCB | Other Identifier | 2025-A01943-46 |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| URC-CIC Paris Descartes Necker Cochin | OTHER |
Not provided
Not provided
Not provided
Not provided
The aim of this study is to compare speech perception in noise with one activated Osia (unilateral) versus two activated Osia (bilateral), in children with high grade microtia/ear atresia fitted with bilateral Osia implants. In order to do these measurements, the enrolled children will get OSIA implants on both sides during a standard surgery procedure. Six months following the implantation, audiologist testing will be done with one implant active compared to both.
High grade microtia corresponds to a congenital malformation of the pinna and the external auditory meatus associated with a malformation of the middle ear. Ear atresia a congenital malformation of the external auditory meatus and middle ear, associated to a normal or near norma pinna.
In the case of hearing loss related to high grade microtia or ear atresia, be the type of hearing rehabilitation cannot be achieved with conventional air-conduction hearing aids, due to the absence of an ear canal. Different options are available and reimbursed by French medical insurance system. The Cochlear Osia implant is a semi-implantable bone conduction hearing aids. It is an active, transcutaneous (closed-skin) implant, which has the CE mark and is covered by the Health Insurance Fund for adults.
When deafness is bilateral and unaided, it impacts the development of oral language, daily life, and academic progress. Studies also show that speech perception in noisy environments is impaired. This can be very disabling, especially for young school-aged children. There are also studies showing that sound localization is improved when using two hearing aids.
Although bilateral fitting has benefits, bone conduction hearing aids are not always surgically placed bilaterally in children with ear aplasia and no clinical research has yet been conducted with the OSIA system. The objective of this study is to evaluate the effectiveness of bilateral implantation of the Osia System in children with high grade microtia or ear atresia.
Once the implantation surgery is done, the patient will come back for at least three visits: two adjustment visits, 1 month and 5 months afterwards, and two ENT consultations at 1 month and 6 months. These visits are part of the usual follow-up for children with bone conduction implants. Experimental audiological measurements will be carried out at the 6-month visit.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Bilateral OSIA2 Implantation | Experimental | Bilateral implantation of two OSIA2 implants during a standard care surgery. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Audiological tests | Other | FraSIMAT (French Simplified Matrix Test) and ERKI tests will be performed with one activated implant versus both activated 6 months after surgery |
|
| Measure | Description | Time Frame |
|---|---|---|
| Implantation success | Successful bilateral versus unilateral implantation identified as an increase of at least 3 dB RSB (signal-to-noise ratio) with bilateral conditions compared to unilateral condition value. | 6 months |
| Measure | Description | Time Frame |
|---|---|---|
| Prosthetic gain | Prosthetic gain measured by preoperative pure-tone and speech audiometry with the removable device preoperatively and with ipsilateral OSIA: | 5 months |
| Prosthetic gain | - Prosthetic gain in pure-tone audiometry (difference in mean air conduction with and without the device) |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Charlotte CELERIER, MD | Contact | 01 71 39 67 85 | +33 | charlotte.celerier@aphp.fr |
| Gael PLASTOW | Contact | 01 44 38 18 57 | +33 | gael.plastow@aphp.fr |
| Name | Affiliation | Role |
|---|---|---|
| Françoise DENOYELLE, MD | Assistance Publique - Hôpitaux de Paris | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Hôpital Necker Enfants Malades | Paris | Île-de-France Region | 75015 | France |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 16619473 | Background | Snik AF, Mylanus EA, Proops DW, Wolfaardt JF, Hodgetts WE, Somers T, Niparko JK, Wazen JJ, Sterkers O, Cremers CW, Tjellstrom A. Consensus statements on the BAHA system: where do we stand at present? Ann Otol Rhinol Laryngol Suppl. 2005 Dec;195:2-12. doi: 10.1177/0003489405114s1201. | |
| 32068449 | Background | Goycoolea M, Ribalta G, Tocornal F, Levy R, Alarcon P, Bryman M, Cagnacci B, Catenacci C, Oyanguren V, Vilches I, Briones V, Garcia R. Clinical performance of the Osia system, a new active osseointegrated implant system. Results from a prospective clinical investigation. Acta Otolaryngol. 2020 Mar;140(3):212-219. doi: 10.1080/00016489.2019.1691744. Epub 2020 Feb 18. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D065817 | Congenital Microtia |
| D003638 | Deafness |
| ID | Term |
|---|---|
| D004427 | Ear Diseases |
| D010038 | Otorhinolaryngologic Diseases |
| D000013 | Congenital Abnormalities |
| D009358 | Congenital, Hereditary, and Neonatal Diseases and Abnormalities |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Speech, Spatial and Qualities of Hearing Scale | Behavioral | The patients will answer the SSQ (Speech, Spatial and Qualities of Hearing Scale) 6 months after his surgery. |
|
| 6 months |
| Prosthetic gain | - Prosthetic gain in speech audiometry (difference in SRT (Speech Reception Threshold) with and without the device) | 6 months |
| Security and skin tolerance | Occurrence of adverse events/serious adverse events, particularly skin complications (hematoma, local injection, skin erosion related to magnetization) | 6 months |
| Sound localization | ERKI localization test with one activated OSIA versus two activated OSIAs | 6 months |
| Hearing quality | Speech and spatial hearing quality scale using the SSQ questionnaire (Speech, Spatial and Qualities of Hearing Scale) scaled between 0 (lowest quality) to 10 points (best quality) | 6 months |
| Daily use | Time length use of OSIA using the data logging OSIA system | 6 months |
| 32925852 | Background | Mylanus EAM, Hua H, Wigren S, Arndt S, Skarzynski PH, Telian SA, Briggs RJS. Multicenter Clinical Investigation of a New Active Osseointegrated Steady-State Implant System. Otol Neurotol. 2020 Oct;41(9):1249-1257. doi: 10.1097/MAO.0000000000002794. |
| 33710155 | Background | Pla-Gil I, Redo MA, Perez-Carbonell T, Martinez-Beneyto P, Alborch MO, Ventura AM, Monteagudo EL, Ribas IP, Algarra JM. Clinical Performance Assessment of a New Active Osseointegrated Implant System in Mixed Hearing Loss: Results From a Prospective Clinical Investigation. Otol Neurotol. 2021 Aug 1;42(7):e905-e910. doi: 10.1097/MAO.0000000000003116. |
| 34792628 | Background | Rauch AK, Wesarg T, Aschendorff A, Speck I, Arndt S. Long-term data of the new transcutaneous partially implantable bone conduction hearing system Osia(R). Eur Arch Otorhinolaryngol. 2022 Sep;279(9):4279-4288. doi: 10.1007/s00405-021-07167-9. Epub 2021 Nov 18. |
| 34687460 | Background | Cushing SL, Gordon KA, Purcell PL, Feness M, Negandhi J, Papsin BC. Surgical Considerations for an Osseointegrated Steady State Implant (OSIA2(R)) in Children. Laryngoscope. 2022 May;132(5):1088-1092. doi: 10.1002/lary.29892. Epub 2021 Oct 23. No abstract available. |
| 23862823 | Background | Stenfelt S, Zeitooni M. Binaural hearing ability with mastoid applied bilateral bone conduction stimulation in normal hearing subjects. J Acoust Soc Am. 2013 Jul;134(1):481-93. doi: 10.1121/1.4807637. |
| 22193619 | Background | Stenfelt S. Transcranial attenuation of bone-conducted sound when stimulation is at the mastoid and at the bone conduction hearing aid position. Otol Neurotol. 2012 Feb;33(2):105-14. doi: 10.1097/MAO.0b013e31823e28ab. |
| 34852723 | Background | Heath E, Dawoud MM, Stavrakas M, Ray J. The outcomes of bilateral bone conduction hearing devices (BCHD) implantation in the treatment of hearing loss: A systematic review. Cochlear Implants Int. 2022 Mar;23(2):95-108. doi: 10.1080/14670100.2021.2001926. Epub 2021 Dec 1. |
| D034381 | Hearing Loss |
| D006311 | Hearing Disorders |
| D012678 | Sensation Disorders |
| D009461 | Neurologic Manifestations |
| D009422 | Nervous System Diseases |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |